🔎 Trials Near Me

Akèy › Kansè kolon › Texas › Dallas

Etid klinik pou Kansè kolon nan Dallas, TX

8 etid pou Kansè kolon ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Ap rekriteFaz 3
  • Texas Oncology - DFW ( Site 8002), Dallas
  • UT Southwestern Medical Center ( Site 0059), Dallas
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06997497

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Ap rekriteFaz 3
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07284849

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Ap rekriteEtid obsèvasyon
  • UT Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Ap rekriteFaz 2/3
  • Parkland Memorial Hospital, Dallas
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05174169

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Ap rekriteFaz 1
  • Sarah Cannon Research Institute at Mary Crowley, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2
  • UT Southwestern Medical Center, Dallas
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Ap rekriteFaz 1/2
  • Mary Crowley Cancer Research, Dallas
Laj 18 ak plis · Tout sèks · Mizajou May 15, 2026 · NCT05379985

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Dallas
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè kolon nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.